

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.90374231 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.90374231 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.62016353 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.62016353 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.20970577 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.87717962 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.68961071 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.68961071 |
| 9 | tryptophan catabolic process (GO:0006569) | 5.68961071 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.51167966 |
| 11 | regulation of guanylate cyclase activity (GO:0031282) | 5.48333129 |
| 12 | tryptophan metabolic process (GO:0006568) | 5.37510987 |
| 13 | bile acid biosynthetic process (GO:0006699) | 5.36383093 |
| 14 | urea cycle (GO:0000050) | 5.33464672 |
| 15 | urea metabolic process (GO:0019627) | 5.33464672 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.24314767 |
| 17 | positive regulation of respiratory burst (GO:0060267) | 5.18550577 |
| 18 | cysteine metabolic process (GO:0006534) | 5.08330544 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 5.08204528 |
| 20 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 4.99149618 |
| 21 | phospholipid efflux (GO:0033700) | 4.99120396 |
| 22 | glyoxylate metabolic process (GO:0046487) | 4.98447619 |
| 23 | regulation of triglyceride catabolic process (GO:0010896) | 4.90064410 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 4.88573519 |
| 25 | serine family amino acid catabolic process (GO:0009071) | 4.88181195 |
| 26 | L-fucose catabolic process (GO:0042355) | 4.84739525 |
| 27 | fucose catabolic process (GO:0019317) | 4.84739525 |
| 28 | L-fucose metabolic process (GO:0042354) | 4.84739525 |
| 29 | negative regulation of fibrinolysis (GO:0051918) | 4.81660692 |
| 30 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 4.79233160 |
| 31 | protein carboxylation (GO:0018214) | 4.78874933 |
| 32 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.78874933 |
| 33 | regulation of fibrinolysis (GO:0051917) | 4.73993938 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 4.73753221 |
| 35 | regulation of cholesterol esterification (GO:0010872) | 4.70897571 |
| 36 | homocysteine metabolic process (GO:0050667) | 4.70603463 |
| 37 | intestinal absorption (GO:0050892) | 4.69881090 |
| 38 | bile acid metabolic process (GO:0008206) | 4.67399923 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.62741099 |
| 40 | regulation of protein activation cascade (GO:2000257) | 4.62474713 |
| 41 | complement activation, alternative pathway (GO:0006957) | 4.57300672 |
| 42 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.53183119 |
| 43 | aromatic amino acid family metabolic process (GO:0009072) | 4.52675021 |
| 44 | reverse cholesterol transport (GO:0043691) | 4.46159362 |
| 45 | negative regulation of cholesterol transport (GO:0032375) | 4.41754263 |
| 46 | negative regulation of sterol transport (GO:0032372) | 4.41754263 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.39645056 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.39645056 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.39645056 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.39627938 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.39627938 |
| 52 | imidazole-containing compound metabolic process (GO:0052803) | 4.38184430 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.35666036 |
| 54 | regulation of complement activation (GO:0030449) | 4.31284091 |
| 55 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.30746176 |
| 56 | bile acid and bile salt transport (GO:0015721) | 4.28986919 |
| 57 | negative regulation of lipase activity (GO:0060192) | 4.27230324 |
| 58 | drug catabolic process (GO:0042737) | 4.23563362 |
| 59 | alpha-amino acid catabolic process (GO:1901606) | 4.22944992 |
| 60 | angiotensin maturation (GO:0002003) | 4.21896105 |
| 61 | tyrosine metabolic process (GO:0006570) | 4.19733538 |
| 62 | desmosome organization (GO:0002934) | 4.16927383 |
| 63 | lysine metabolic process (GO:0006553) | 4.13608299 |
| 64 | lysine catabolic process (GO:0006554) | 4.13608299 |
| 65 | fibrinolysis (GO:0042730) | 4.10692149 |
| 66 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 4.06965939 |
| 67 | regulation of bile acid biosynthetic process (GO:0070857) | 4.04598893 |
| 68 | amine catabolic process (GO:0009310) | 4.02688317 |
| 69 | cellular biogenic amine catabolic process (GO:0042402) | 4.02688317 |
| 70 | indolalkylamine metabolic process (GO:0006586) | 4.01430187 |
| 71 | glutamate metabolic process (GO:0006536) | 4.00079677 |
| 72 | sulfate transmembrane transport (GO:1902358) | 3.97958683 |
| 73 | oligosaccharide biosynthetic process (GO:0009312) | 3.97769147 |
| 74 | glycine metabolic process (GO:0006544) | 3.96172152 |
| 75 | cellular ketone body metabolic process (GO:0046950) | 3.95422538 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 3.95042658 |
| 77 | cholesterol efflux (GO:0033344) | 3.95007298 |
| 78 | regulation of cholesterol homeostasis (GO:2000188) | 3.93958573 |
| 79 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 3.93093221 |
| 80 | cellular glucuronidation (GO:0052695) | 3.91477406 |
| 81 | cellular amino acid catabolic process (GO:0009063) | 3.90519050 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 3.89504870 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.87811311 |
| 84 | cellular modified amino acid catabolic process (GO:0042219) | 3.83256332 |
| 85 | epoxygenase P450 pathway (GO:0019373) | 3.82114893 |
| 86 | arginine metabolic process (GO:0006525) | 3.79777542 |
| 87 | plasma lipoprotein particle assembly (GO:0034377) | 3.77300931 |
| 88 | coenzyme catabolic process (GO:0009109) | 3.76862388 |
| 89 | ethanol oxidation (GO:0006069) | 3.74653013 |
| 90 | vitamin transmembrane transport (GO:0035461) | 3.74286111 |
| 91 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.73092897 |
| 92 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.73092897 |
| 93 | intestinal cholesterol absorption (GO:0030299) | 3.72621032 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.70138587 |
| 95 | axonemal dynein complex assembly (GO:0070286) | 3.69000945 |
| 96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67692113 |
| 97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67692113 |
| 98 | fucosylation (GO:0036065) | 3.65871272 |
| 99 | carnitine metabolic process (GO:0009437) | 3.64116255 |
| 100 | sterol homeostasis (GO:0055092) | 3.63149015 |
| 101 | exogenous drug catabolic process (GO:0042738) | 3.62915851 |
| 102 | short-chain fatty acid metabolic process (GO:0046459) | 3.61387568 |
| 103 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.60559178 |
| 104 | ethanol metabolic process (GO:0006067) | 3.57434380 |
| 105 | serine family amino acid biosynthetic process (GO:0009070) | 3.55064452 |
| 106 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 3.53477197 |
| 107 | linoleic acid metabolic process (GO:0043651) | 3.52922849 |
| 108 | flavonoid metabolic process (GO:0009812) | 3.52560849 |
| 109 | primary alcohol catabolic process (GO:0034310) | 3.52103737 |
| 110 | regulation of cellular extravasation (GO:0002691) | 3.51237106 |
| 111 | very long-chain fatty acid metabolic process (GO:0000038) | 3.49475913 |
| 112 | positive regulation of lipid catabolic process (GO:0050996) | 3.49359409 |
| 113 | glucuronate metabolic process (GO:0019585) | 3.47080962 |
| 114 | uronic acid metabolic process (GO:0006063) | 3.47080962 |
| 115 | drug metabolic process (GO:0017144) | 3.45811967 |
| 116 | organic acid catabolic process (GO:0016054) | 3.45097181 |
| 117 | carboxylic acid catabolic process (GO:0046395) | 3.45097181 |
| 118 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.41477485 |
| 119 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.41448854 |
| 120 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.41381565 |
| 121 | ketone body metabolic process (GO:1902224) | 3.40931422 |
| 122 | establishment of skin barrier (GO:0061436) | 3.40880150 |
| 123 | multicellular organismal water homeostasis (GO:0050891) | 3.40681079 |
| 124 | fatty acid elongation (GO:0030497) | 3.40103651 |
| 125 | blood coagulation, intrinsic pathway (GO:0007597) | 3.38749309 |
| 126 | low-density lipoprotein particle remodeling (GO:0034374) | 3.38460482 |
| 127 | regulation of respiratory burst (GO:0060263) | 3.37182681 |
| 128 | glomerular filtration (GO:0003094) | 3.35180076 |
| 129 | digestion (GO:0007586) | 3.34332266 |
| 130 | lipoprotein metabolic process (GO:0042157) | 3.34018709 |
| 131 | protein-lipid complex assembly (GO:0065005) | 3.32684416 |
| 132 | intestinal epithelial cell development (GO:0060576) | 3.28477254 |
| 133 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.28206857 |
| 134 | sulfate transport (GO:0008272) | 3.26888256 |
| 135 | transepithelial transport (GO:0070633) | 3.24402766 |
| 136 | regulation of cGMP biosynthetic process (GO:0030826) | 3.21845517 |
| 137 | sulfur compound transport (GO:0072348) | 3.21395028 |
| 138 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.20281019 |
| 139 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.20150940 |
| 140 | endocrine process (GO:0050886) | 3.20150940 |
| 141 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.20150940 |
| 142 | transcytosis (GO:0045056) | 3.19645885 |
| 143 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.19112697 |
| 144 | sulfation (GO:0051923) | 3.17285072 |
| 145 | excretion (GO:0007588) | 3.16822739 |
| 146 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.15765884 |
| 147 | auditory receptor cell differentiation (GO:0042491) | 3.14729309 |
| 148 | phosphatidylserine metabolic process (GO:0006658) | 3.06389500 |
| 149 | renal system process involved in regulation of blood volume (GO:0001977) | 3.05551313 |
| 150 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.04513039 |
| 151 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.03555872 |
| 152 | arginine catabolic process (GO:0006527) | 3.03057346 |
| 153 | cilium movement (GO:0003341) | 3.02553100 |
| 154 | regulation of water loss via skin (GO:0033561) | 3.02456618 |
| 155 | regulation of protein glycosylation (GO:0060049) | 3.01621421 |
| 156 | water homeostasis (GO:0030104) | 3.00209450 |
| 157 | quinone biosynthetic process (GO:1901663) | 2.97848472 |
| 158 | regulation of systemic arterial blood pressure (GO:0003073) | 2.96883447 |
| 159 | O-glycan processing (GO:0016266) | 2.96147572 |
| 160 | positive regulation of fatty acid oxidation (GO:0046321) | 2.93727021 |
| 161 | bicarbonate transport (GO:0015701) | 2.92546146 |
| 162 | epithelial cilium movement (GO:0003351) | 2.91987588 |
| 163 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.91709105 |
| 164 | axoneme assembly (GO:0035082) | 2.91347602 |
| 165 | antibacterial humoral response (GO:0019731) | 2.90832005 |
| 166 | glycerol metabolic process (GO:0006071) | 2.89870762 |
| 167 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.89237231 |
| 168 | antimicrobial humoral response (GO:0019730) | 2.86047827 |
| 169 | renal filtration (GO:0097205) | 2.85979863 |
| 170 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.81184386 |
| 171 | kidney morphogenesis (GO:0060993) | 2.78671245 |
| 172 | vitamin biosynthetic process (GO:0009110) | 2.76373447 |
| 173 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.75910332 |
| 174 | positive regulation of fatty acid transport (GO:2000193) | 2.75889086 |
| 175 | alkaloid metabolic process (GO:0009820) | 2.75153706 |
| 176 | regulation of cGMP metabolic process (GO:0030823) | 2.74327842 |
| 177 | primary alcohol metabolic process (GO:0034308) | 2.72258480 |
| 178 | positive regulation of pseudopodium assembly (GO:0031274) | 2.71203256 |
| 179 | alditol phosphate metabolic process (GO:0052646) | 2.69799446 |
| 180 | keratinization (GO:0031424) | 2.68570946 |
| 181 | phosphatidylcholine metabolic process (GO:0046470) | 2.66510806 |
| 182 | digestive system process (GO:0022600) | 2.66364610 |
| 183 | one-carbon compound transport (GO:0019755) | 2.66044297 |
| 184 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.63509663 |
| 185 | positive regulation of icosanoid secretion (GO:0032305) | 2.61455826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.85975487 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.94312167 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.68609573 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.13651510 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.82930260 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.42579758 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.51698381 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.47474980 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.06896141 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.95157267 |
| 11 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.39026725 |
| 12 | VDR_22108803_ChIP-Seq_LS180_Human | 2.87850639 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.82208510 |
| 14 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.59921302 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.24792391 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88211498 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85290637 |
| 18 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.75572157 |
| 19 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75082482 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.74176822 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.70418526 |
| 22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.67833615 |
| 23 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.61324788 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.58957565 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.56145239 |
| 26 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.52349762 |
| 27 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.51373255 |
| 28 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.50986286 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50958849 |
| 30 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.47861937 |
| 31 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.47487105 |
| 32 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.47323343 |
| 33 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.47323343 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47157011 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44675697 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43475051 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43258962 |
| 38 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42168556 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.42045036 |
| 40 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.40960590 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40675047 |
| 42 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.39848572 |
| 43 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39721375 |
| 44 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.36620730 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.35215868 |
| 46 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.34322302 |
| 47 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33848114 |
| 48 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.32610854 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.31669582 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.29289006 |
| 51 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.29061420 |
| 52 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.29014399 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26945042 |
| 54 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26830399 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26704470 |
| 56 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.25180258 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.24385101 |
| 58 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.24185507 |
| 59 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.22349550 |
| 60 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.21849768 |
| 61 | NCOR_22424771_ChIP-Seq_293T_Human | 1.21624670 |
| 62 | RXR_22108803_ChIP-Seq_LS180_Human | 1.20810947 |
| 63 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19241830 |
| 64 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.18488625 |
| 65 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.17623357 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.16393301 |
| 67 | AR_25329375_ChIP-Seq_VCAP_Human | 1.15569103 |
| 68 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.15518856 |
| 69 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15287122 |
| 70 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.13817122 |
| 71 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13711468 |
| 72 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13348133 |
| 73 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.11290320 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.10976517 |
| 75 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10432240 |
| 76 | P300_19829295_ChIP-Seq_ESCs_Human | 1.08732333 |
| 77 | ERA_21632823_ChIP-Seq_H3396_Human | 1.08137483 |
| 78 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.08074183 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07092451 |
| 80 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.06655449 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.06547207 |
| 82 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06020164 |
| 83 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05982089 |
| 84 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05982089 |
| 85 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.05616819 |
| 86 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04406632 |
| 87 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.02888040 |
| 88 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.01615203 |
| 89 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01306349 |
| 90 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01143760 |
| 91 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00373957 |
| 92 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.98987433 |
| 93 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98666971 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98666971 |
| 95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.98515599 |
| 96 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97877016 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.97597640 |
| 98 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97554294 |
| 99 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.97010310 |
| 100 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.96761408 |
| 101 | TCF4_23295773_ChIP-Seq_U87_Human | 0.95595219 |
| 102 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.94707723 |
| 103 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.94158551 |
| 104 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.92797684 |
| 105 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92056252 |
| 106 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.90790143 |
| 107 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88308960 |
| 108 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.87591876 |
| 109 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87056786 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.86576989 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82074802 |
| 112 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.81957562 |
| 113 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80148170 |
| 114 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79028527 |
| 115 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.78154555 |
| 116 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74033332 |
| 117 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73178770 |
| 118 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.72806510 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72026498 |
| 120 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.71315600 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.69599057 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69257715 |
| 123 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67626439 |
| 124 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67165946 |
| 125 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.67058425 |
| 126 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.67058425 |
| 127 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.66688308 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.66422339 |
| 129 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.66313111 |
| 130 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.66305282 |
| 131 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.66305282 |
| 132 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.66002345 |
| 133 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.65164804 |
| 134 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63735947 |
| 135 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63193754 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.62492745 |
| 137 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.62136804 |
| 138 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60807627 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.58662413 |
| 140 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.58106725 |
| 141 | ATF3_27146783_Chip-Seq_COLON_Human | 0.57870588 |
| 142 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.57278310 |
| 143 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56853849 |
| 144 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56704093 |
| 145 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.56095154 |
| 146 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.55551087 |
| 147 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.55196187 |
| 148 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.55100786 |
| 149 | CJUN_26792858_Chip-Seq_BT549_Human | 0.54189134 |
| 150 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53727246 |
| 151 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53102640 |
| 152 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.52396531 |
| 153 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.52105525 |
| 154 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.51735846 |
| 155 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.51233073 |
| 156 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.50080344 |
| 157 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.49750546 |
| 158 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.48398725 |
| 159 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.48248804 |
| 160 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48240286 |
| 161 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.47847620 |
| 162 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.47781833 |
| 163 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.47576427 |
| 164 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.47522192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.92797938 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 6.86217293 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.63591575 |
| 4 | MP0005365_abnormal_bile_salt | 5.29760183 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.54308818 |
| 6 | MP0004043_abnormal_pH_regulation | 4.06193344 |
| 7 | MP0002796_impaired_skin_barrier | 3.58591294 |
| 8 | MP0003252_abnormal_bile_duct | 3.35085042 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.10132068 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.03053070 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.96055585 |
| 12 | MP0009840_abnormal_foam_cell | 2.86986099 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.80918563 |
| 14 | MP0004147_increased_porphyrin_level | 2.69527499 |
| 15 | MP0003195_calcinosis | 2.55500073 |
| 16 | MP0005451_abnormal_body_composition | 2.54933738 |
| 17 | MP0002254_reproductive_system_inflammat | 2.51183129 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.41200231 |
| 19 | MP0004019_abnormal_vitamin_homeostasis | 2.38053701 |
| 20 | MP0005083_abnormal_biliary_tract | 2.37564429 |
| 21 | MP0005332_abnormal_amino_acid | 2.36224120 |
| 22 | MP0001664_abnormal_digestion | 2.23611676 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.08866137 |
| 24 | MP0001873_stomach_inflammation | 2.06038258 |
| 25 | MP0003866_abnormal_defecation | 2.04174165 |
| 26 | MP0004381_abnormal_hair_follicle | 2.02283405 |
| 27 | MP0008872_abnormal_physiological_respon | 1.97008699 |
| 28 | MP0005501_abnormal_skin_physiology | 1.92711922 |
| 29 | MP0002118_abnormal_lipid_homeostasis | 1.76362076 |
| 30 | MP0000609_abnormal_liver_physiology | 1.74856485 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.74477562 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.72262691 |
| 33 | MP0001188_hyperpigmentation | 1.69344912 |
| 34 | MP0004885_abnormal_endolymph | 1.64536377 |
| 35 | MP0002138_abnormal_hepatobiliary_system | 1.63657042 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.59558032 |
| 37 | MP0002060_abnormal_skin_morphology | 1.57803743 |
| 38 | MP0001485_abnormal_pinna_reflex | 1.53390096 |
| 39 | MP0000579_abnormal_nail_morphology | 1.51078683 |
| 40 | MP0005275_abnormal_skin_tensile | 1.50486304 |
| 41 | MP0010678_abnormal_skin_adnexa | 1.48835375 |
| 42 | MP0003868_abnormal_feces_composition | 1.48370731 |
| 43 | MP0002098_abnormal_vibrissa_morphology | 1.47939316 |
| 44 | MP0001663_abnormal_digestive_system | 1.45975647 |
| 45 | MP0001216_abnormal_epidermal_layer | 1.45269163 |
| 46 | MP0003011_delayed_dark_adaptation | 1.43902718 |
| 47 | MP0003453_abnormal_keratinocyte_physiol | 1.40256171 |
| 48 | MP0003941_abnormal_skin_development | 1.40166519 |
| 49 | MP0005319_abnormal_enzyme/_coenzyme | 1.39497348 |
| 50 | MP0009379_abnormal_foot_pigmentation | 1.34165249 |
| 51 | MP0000383_abnormal_hair_follicle | 1.33850480 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.28260159 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.28095214 |
| 54 | MP0009643_abnormal_urine_homeostasis | 1.23793401 |
| 55 | MP0001764_abnormal_homeostasis | 1.23767159 |
| 56 | MP0005647_abnormal_sex_gland | 1.21966232 |
| 57 | MP0000477_abnormal_intestine_morphology | 1.17113542 |
| 58 | MP0010771_integument_phenotype | 1.16729317 |
| 59 | MP0005381_digestive/alimentary_phenotyp | 1.16183643 |
| 60 | MP0009780_abnormal_chondrocyte_physiolo | 1.15152307 |
| 61 | MP0010386_abnormal_urinary_bladder | 1.14236332 |
| 62 | MP0000647_abnormal_sebaceous_gland | 1.14172971 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09683886 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.09406717 |
| 65 | MP0002653_abnormal_ependyma_morphology | 1.08671550 |
| 66 | MP0000377_abnormal_hair_follicle | 1.08030388 |
| 67 | MP0000566_synostosis | 1.07376099 |
| 68 | MP0000230_abnormal_systemic_arterial | 1.03776696 |
| 69 | MP0000467_abnormal_esophagus_morphology | 1.02995814 |
| 70 | MP0005310_abnormal_salivary_gland | 1.01651099 |
| 71 | MP0000516_abnormal_urinary_system | 1.01512041 |
| 72 | MP0005367_renal/urinary_system_phenotyp | 1.01512041 |
| 73 | MP0000427_abnormal_hair_cycle | 0.96507951 |
| 74 | MP0004947_skin_inflammation | 0.96370515 |
| 75 | MP0009697_abnormal_copulation | 0.95958384 |
| 76 | MP0000465_gastrointestinal_hemorrhage | 0.95123260 |
| 77 | MP0005636_abnormal_mineral_homeostasis | 0.91882094 |
| 78 | MP0005645_abnormal_hypothalamus_physiol | 0.91880070 |
| 79 | MP0009053_abnormal_anal_canal | 0.89724364 |
| 80 | MP0009764_decreased_sensitivity_to | 0.89650250 |
| 81 | MP0001346_abnormal_lacrimal_gland | 0.89236816 |
| 82 | MP0000470_abnormal_stomach_morphology | 0.87823836 |
| 83 | MP0003186_abnormal_redox_activity | 0.87510833 |
| 84 | MP0000678_abnormal_parathyroid_gland | 0.87285963 |
| 85 | MP0000490_abnormal_crypts_of | 0.87232859 |
| 86 | MP0005408_hypopigmentation | 0.86483283 |
| 87 | MP0004782_abnormal_surfactant_physiolog | 0.81651785 |
| 88 | MP0000462_abnormal_digestive_system | 0.81630041 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.80748333 |
| 90 | MP0002095_abnormal_skin_pigmentation | 0.79470278 |
| 91 | MP0010352_gastrointestinal_tract_polyps | 0.78384730 |
| 92 | MP0009931_abnormal_skin_appearance | 0.78305406 |
| 93 | MP0004185_abnormal_adipocyte_glucose | 0.78087196 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.77144279 |
| 95 | MP0001191_abnormal_skin_condition | 0.76301252 |
| 96 | MP0000598_abnormal_liver_morphology | 0.75774803 |
| 97 | MP0005075_abnormal_melanosome_morpholog | 0.75609920 |
| 98 | MP0003878_abnormal_ear_physiology | 0.74786053 |
| 99 | MP0005377_hearing/vestibular/ear_phenot | 0.74786053 |
| 100 | MP0009763_increased_sensitivity_to | 0.74241131 |
| 101 | MP0001919_abnormal_reproductive_system | 0.73926201 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 0.72933166 |
| 103 | MP0003045_fibrosis | 0.72911988 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.71752711 |
| 105 | MP0003283_abnormal_digestive_organ | 0.71514669 |
| 106 | MP0003718_maternal_effect | 0.70557768 |
| 107 | MP0000604_amyloidosis | 0.68337593 |
| 108 | MP0002938_white_spotting | 0.68294020 |
| 109 | MP0001243_abnormal_dermal_layer | 0.67613755 |
| 110 | MP0002909_abnormal_adrenal_gland | 0.66412661 |
| 111 | MP0002102_abnormal_ear_morphology | 0.66380551 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.66197315 |
| 113 | MP0003638_abnormal_response/metabolism_ | 0.65402064 |
| 114 | MP0009642_abnormal_blood_homeostasis | 0.65199574 |
| 115 | MP0003953_abnormal_hormone_level | 0.64770322 |
| 116 | MP0008469_abnormal_protein_level | 0.64220539 |
| 117 | MP0005389_reproductive_system_phenotype | 0.64190298 |
| 118 | MP0005409_darkened_coat_color | 0.63777241 |
| 119 | MP0002971_abnormal_brown_adipose | 0.62729638 |
| 120 | MP0001756_abnormal_urination | 0.62147718 |
| 121 | MP0005166_decreased_susceptibility_to | 0.61789341 |
| 122 | MP0001968_abnormal_touch/_nociception | 0.59354615 |
| 123 | MP0000367_abnormal_coat/_hair | 0.59229188 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.58140242 |
| 125 | MP0002638_abnormal_pupillary_reflex | 0.57517191 |
| 126 | MP0004484_altered_response_of | 0.57452392 |
| 127 | MP0002136_abnormal_kidney_physiology | 0.57425594 |
| 128 | MP0000538_abnormal_urinary_bladder | 0.56439535 |
| 129 | MP0010368_abnormal_lymphatic_system | 0.54540351 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.54124569 |
| 131 | MP0005376_homeostasis/metabolism_phenot | 0.51021117 |
| 132 | MP0005084_abnormal_gallbladder_morpholo | 0.50280471 |
| 133 | MP0005666_abnormal_adipose_tissue | 0.46913409 |
| 134 | MP0005395_other_phenotype | 0.45388322 |
| 135 | MP0003724_increased_susceptibility_to | 0.44866438 |
| 136 | MP0005334_abnormal_fat_pad | 0.43878949 |
| 137 | MP0003436_decreased_susceptibility_to | 0.43851090 |
| 138 | MP0005023_abnormal_wound_healing | 0.43372446 |
| 139 | MP0001340_abnormal_eyelid_morphology | 0.41940915 |
| 140 | MP0005448_abnormal_energy_balance | 0.41775495 |
| 141 | MP0005670_abnormal_white_adipose | 0.41759049 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.41283426 |
| 143 | MP0002132_abnormal_respiratory_system | 0.40593397 |
| 144 | MP0003329_amyloid_beta_deposits | 0.39745675 |
| 145 | MP0000762_abnormal_tongue_morphology | 0.39460162 |
| 146 | MP0001765_abnormal_ion_homeostasis | 0.39375948 |
| 147 | MP0005187_abnormal_penis_morphology | 0.36442714 |
| 148 | MP0005266_abnormal_metabolism | 0.35579169 |
| 149 | MP0003690_abnormal_glial_cell | 0.34323504 |
| 150 | MP0001881_abnormal_mammary_gland | 0.33557613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 6.80410563 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.53340823 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.30439098 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.21831378 |
| 5 | Xanthomatosis (HP:0000991) | 5.97977301 |
| 6 | Hyperactive renin-angiotensin system (HP:0000841) | 5.89687988 |
| 7 | Decreased circulating renin level (HP:0003351) | 5.85454671 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.72543114 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 5.71185976 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.93929635 |
| 11 | Abnormality of renin-angiotensin system (HP:0000847) | 4.87586061 |
| 12 | Metabolic alkalosis (HP:0200114) | 4.75697907 |
| 13 | Complement deficiency (HP:0004431) | 4.43019929 |
| 14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.38407910 |
| 15 | Hypolipoproteinemia (HP:0010981) | 4.36020822 |
| 16 | Epidermoid cyst (HP:0200040) | 4.31060690 |
| 17 | Hyperammonemia (HP:0001987) | 4.20242911 |
| 18 | Hyperglycinemia (HP:0002154) | 4.14578719 |
| 19 | Hyperglycinuria (HP:0003108) | 4.07057860 |
| 20 | Fat malabsorption (HP:0002630) | 4.03971266 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.98399908 |
| 22 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94801590 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 3.94801590 |
| 24 | Joint hemorrhage (HP:0005261) | 3.93091586 |
| 25 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.87215938 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.86526459 |
| 27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.84066936 |
| 28 | Ketosis (HP:0001946) | 3.70929854 |
| 29 | Abnormality of the common coagulation pathway (HP:0010990) | 3.70010168 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69768869 |
| 31 | Hyperaldosteronism (HP:0000859) | 3.68926561 |
| 32 | Abnormality of chloride homeostasis (HP:0011422) | 3.62546977 |
| 33 | Absent/shortened dynein arms (HP:0200106) | 3.62054548 |
| 34 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.62054548 |
| 35 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.60557391 |
| 36 | Abnormality of methionine metabolism (HP:0010901) | 3.58443674 |
| 37 | Chronic bronchitis (HP:0004469) | 3.50566097 |
| 38 | Abnormality of complement system (HP:0005339) | 3.45261098 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.40611892 |
| 40 | Congenital sensorineural hearing impairment (HP:0008527) | 3.40126689 |
| 41 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.39474245 |
| 42 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.39474245 |
| 43 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.32242514 |
| 44 | Abnormality of vitamin B metabolism (HP:0004340) | 3.27606002 |
| 45 | Pili torti (HP:0003777) | 3.15395210 |
| 46 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.15055748 |
| 47 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.11803198 |
| 48 | Abnormal ciliary motility (HP:0012262) | 3.11766130 |
| 49 | Hypercholesterolemia (HP:0003124) | 3.10538351 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.03968157 |
| 51 | Abnormality of the intrinsic pathway (HP:0010989) | 3.03539665 |
| 52 | Steatorrhea (HP:0002570) | 3.02197228 |
| 53 | Rhinitis (HP:0012384) | 3.00213271 |
| 54 | Right ventricular cardiomyopathy (HP:0011663) | 2.97451488 |
| 55 | Vascular calcification (HP:0004934) | 2.92410663 |
| 56 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.85949538 |
| 57 | Hyperbilirubinemia (HP:0002904) | 2.85568687 |
| 58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.83515578 |
| 59 | Pancreatic cysts (HP:0001737) | 2.80528210 |
| 60 | Chronic diarrhea (HP:0002028) | 2.79915549 |
| 61 | Abnormality of nucleobase metabolism (HP:0010932) | 2.78979978 |
| 62 | Ketoacidosis (HP:0001993) | 2.76585044 |
| 63 | Malnutrition (HP:0004395) | 2.76138290 |
| 64 | Abnormality of the renal cortex (HP:0011035) | 2.74899380 |
| 65 | True hermaphroditism (HP:0010459) | 2.73926769 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.73783902 |
| 67 | Hypokalemia (HP:0002900) | 2.73729673 |
| 68 | Delayed CNS myelination (HP:0002188) | 2.71174500 |
| 69 | Myocardial infarction (HP:0001658) | 2.70792800 |
| 70 | Tubular atrophy (HP:0000092) | 2.70087233 |
| 71 | Bronchiectasis (HP:0002110) | 2.69672949 |
| 72 | Parakeratosis (HP:0001036) | 2.65191690 |
| 73 | Abnormality of purine metabolism (HP:0004352) | 2.62568368 |
| 74 | Hyperventilation (HP:0002883) | 2.62047023 |
| 75 | Abnormality of serum amino acid levels (HP:0003112) | 2.60297255 |
| 76 | Abnormal hair laboratory examination (HP:0003328) | 2.58731718 |
| 77 | Metabolic acidosis (HP:0001942) | 2.58000428 |
| 78 | Spontaneous abortion (HP:0005268) | 2.57760893 |
| 79 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57372518 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 2.57372518 |
| 81 | Cardiovascular calcification (HP:0011915) | 2.57267196 |
| 82 | Abnormality of midbrain morphology (HP:0002418) | 2.54772614 |
| 83 | Molar tooth sign on MRI (HP:0002419) | 2.54772614 |
| 84 | Renal salt wasting (HP:0000127) | 2.48510793 |
| 85 | Abnormality of potassium homeostasis (HP:0011042) | 2.47335944 |
| 86 | Gout (HP:0001997) | 2.45436545 |
| 87 | Plantar hyperkeratosis (HP:0007556) | 2.39759971 |
| 88 | Hypotrichosis (HP:0001006) | 2.39690997 |
| 89 | Rickets (HP:0002748) | 2.38466018 |
| 90 | Lethargy (HP:0001254) | 2.38412849 |
| 91 | Abnormality of the renal medulla (HP:0100957) | 2.34865461 |
| 92 | Pancreatic fibrosis (HP:0100732) | 2.33947157 |
| 93 | Systemic lupus erythematosus (HP:0002725) | 2.32422414 |
| 94 | Hyperkalemia (HP:0002153) | 2.32110926 |
| 95 | Nephronophthisis (HP:0000090) | 2.32033147 |
| 96 | Hepatocellular carcinoma (HP:0001402) | 2.30555316 |
| 97 | Amyloidosis (HP:0011034) | 2.30126155 |
| 98 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.22933719 |
| 99 | Pigmentary retinal degeneration (HP:0001146) | 2.20429625 |
| 100 | Erythroderma (HP:0001019) | 2.20077133 |
| 101 | Furrowed tongue (HP:0000221) | 2.19811142 |
| 102 | Ileus (HP:0002595) | 2.19571644 |
| 103 | Spastic diplegia (HP:0001264) | 2.18835062 |
| 104 | Acanthocytosis (HP:0001927) | 2.18557965 |
| 105 | Neonatal onset (HP:0003623) | 2.18245804 |
| 106 | Hydroxyprolinuria (HP:0003080) | 2.17489270 |
| 107 | Abnormality of proline metabolism (HP:0010907) | 2.17489270 |
| 108 | Alkalosis (HP:0001948) | 2.17249495 |
| 109 | Onycholysis (HP:0001806) | 2.17222104 |
| 110 | Stomach cancer (HP:0012126) | 2.16112276 |
| 111 | Skin nodule (HP:0200036) | 2.14061689 |
| 112 | Amelogenesis imperfecta (HP:0000705) | 2.14024814 |
| 113 | Irritability (HP:0000737) | 2.13956551 |
| 114 | Palmoplantar hyperkeratosis (HP:0000972) | 2.13220960 |
| 115 | Cerebral edema (HP:0002181) | 2.11061051 |
| 116 | Increased IgE level (HP:0003212) | 2.10766522 |
| 117 | Fragile nails (HP:0001808) | 2.10717199 |
| 118 | Dehydration (HP:0001944) | 2.10384420 |
| 119 | Conjunctival hamartoma (HP:0100780) | 2.10206648 |
| 120 | Hyponatremia (HP:0002902) | 2.09110741 |
| 121 | Confusion (HP:0001289) | 2.08236365 |
| 122 | Late onset (HP:0003584) | 2.07250750 |
| 123 | Congenital, generalized hypertrichosis (HP:0004540) | 2.06215456 |
| 124 | Woolly hair (HP:0002224) | 2.05384131 |
| 125 | Alopecia of scalp (HP:0002293) | 2.05179439 |
| 126 | Glomerulonephritis (HP:0000099) | 2.04422758 |
| 127 | Hypochromic microcytic anemia (HP:0004840) | 2.04106573 |
| 128 | Bronchitis (HP:0012387) | 2.04090213 |
| 129 | Esophageal varix (HP:0002040) | 2.02422692 |
| 130 | Pancreatitis (HP:0001733) | 2.02105579 |
| 131 | Cystic liver disease (HP:0006706) | 2.01522209 |
| 132 | Widely patent fontanelles and sutures (HP:0004492) | 2.01357017 |
| 133 | Abnormality of macular pigmentation (HP:0008002) | 2.00181358 |
| 134 | Cerebral palsy (HP:0100021) | 1.97597288 |
| 135 | Hypokalemic alkalosis (HP:0001949) | 1.97504241 |
| 136 | Abnormal hemoglobin (HP:0011902) | 1.96704393 |
| 137 | Abnormal gallbladder morphology (HP:0012437) | 1.96145951 |
| 138 | Abnormality of nail color (HP:0100643) | 1.94943822 |
| 139 | Abnormality of urine glucose concentration (HP:0011016) | 1.94592250 |
| 140 | Glycosuria (HP:0003076) | 1.94592250 |
| 141 | Hypophosphatemic rickets (HP:0004912) | 1.94309787 |
| 142 | Abnormality of magnesium homeostasis (HP:0004921) | 1.94153263 |
| 143 | Palmar hyperkeratosis (HP:0010765) | 1.94067424 |
| 144 | Brushfield spots (HP:0001088) | 1.93494533 |
| 145 | Abnormality of renal excretion (HP:0011036) | 1.92952156 |
| 146 | Abolished electroretinogram (ERG) (HP:0000550) | 1.92634645 |
| 147 | Abnormality of the axillary hair (HP:0100134) | 1.92448433 |
| 148 | Abnormality of secondary sexual hair (HP:0009888) | 1.92448433 |
| 149 | Hypoglycemic seizures (HP:0002173) | 1.92311039 |
| 150 | Gangrene (HP:0100758) | 1.92307598 |
| 151 | Generalized aminoaciduria (HP:0002909) | 1.91566557 |
| 152 | Abnormal cartilage morphology (HP:0002763) | 1.91220693 |
| 153 | Syncope (HP:0001279) | 1.90340893 |
| 154 | Vomiting (HP:0002013) | 1.90204275 |
| 155 | Cholelithiasis (HP:0001081) | 1.90169907 |
| 156 | Mitral stenosis (HP:0001718) | 1.87653292 |
| 157 | Abnormality of vitamin metabolism (HP:0100508) | 1.86449210 |
| 158 | Chronic sinusitis (HP:0011109) | 1.85322659 |
| 159 | Curly hair (HP:0002212) | 1.84195570 |
| 160 | Hypoalbuminemia (HP:0003073) | 1.82072114 |
| 161 | Abnormal albumin level (HP:0012116) | 1.82072114 |
| 162 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.79602947 |
| 163 | Concave nail (HP:0001598) | 1.77506368 |
| 164 | Methylmalonic aciduria (HP:0012120) | 1.75000715 |
| 165 | Abnormality of sodium homeostasis (HP:0010931) | 1.73702784 |
| 166 | Pendular nystagmus (HP:0012043) | 1.73045287 |
| 167 | Proximal tubulopathy (HP:0000114) | 1.71358133 |
| 168 | Nasal polyposis (HP:0100582) | 1.69913277 |
| 169 | Abnormal biliary tract morphology (HP:0012440) | 1.69903525 |
| 170 | Abdominal distention (HP:0003270) | 1.69192592 |
| 171 | Villous atrophy (HP:0011473) | 1.69088040 |
| 172 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.69088040 |
| 173 | Abnormal drinking behavior (HP:0030082) | 1.68710159 |
| 174 | Polydipsia (HP:0001959) | 1.68710159 |
| 175 | Hamartoma of the eye (HP:0010568) | 1.68526450 |
| 176 | Abnormality of the nasal mucosa (HP:0000433) | 1.67319965 |
| 177 | Attenuation of retinal blood vessels (HP:0007843) | 1.65948047 |
| 178 | Renal cortical cysts (HP:0000803) | 1.65699362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.03794742 |
| 2 | ACVR1B | 5.12059481 |
| 3 | BCKDK | 4.66256952 |
| 4 | ERN1 | 3.89585834 |
| 5 | FGFR4 | 3.85935555 |
| 6 | SIK1 | 2.87767088 |
| 7 | ADRBK2 | 2.78809034 |
| 8 | STK39 | 2.68382040 |
| 9 | MAP3K3 | 2.63644123 |
| 10 | PIK3CA | 2.52325753 |
| 11 | ERBB4 | 2.51007504 |
| 12 | LATS1 | 2.46679369 |
| 13 | MAPKAPK3 | 2.26909947 |
| 14 | EPHB2 | 2.17594904 |
| 15 | WNK4 | 2.09207797 |
| 16 | WNK3 | 2.08736722 |
| 17 | MAP4K2 | 2.07137324 |
| 18 | MET | 2.05911962 |
| 19 | BMPR1B | 1.98621324 |
| 20 | FRK | 1.97395629 |
| 21 | LMTK2 | 1.91864857 |
| 22 | PIK3CG | 1.91274553 |
| 23 | CASK | 1.89861085 |
| 24 | INSRR | 1.76024847 |
| 25 | TYK2 | 1.68676205 |
| 26 | FGFR2 | 1.65210354 |
| 27 | MAPK11 | 1.62349331 |
| 28 | TAOK3 | 1.58104135 |
| 29 | MST4 | 1.52734071 |
| 30 | PRKG2 | 1.52165322 |
| 31 | MAP3K2 | 1.51784454 |
| 32 | FER | 1.48008651 |
| 33 | STK38L | 1.43535610 |
| 34 | PTK6 | 1.42444982 |
| 35 | TLK1 | 1.39044519 |
| 36 | MAPK13 | 1.38914981 |
| 37 | MAP2K6 | 1.31593888 |
| 38 | MAPK15 | 1.30435612 |
| 39 | ZAK | 1.23959459 |
| 40 | TNIK | 1.23565118 |
| 41 | MAP2K4 | 1.21481866 |
| 42 | MAP3K14 | 1.18176498 |
| 43 | NME1 | 1.17809686 |
| 44 | DYRK1B | 1.17525570 |
| 45 | GRK1 | 1.14876792 |
| 46 | NEK9 | 1.13713647 |
| 47 | EPHA2 | 1.13653466 |
| 48 | MAP2K2 | 1.11613025 |
| 49 | ERBB2 | 1.08871724 |
| 50 | TXK | 1.08580403 |
| 51 | ABL2 | 1.05891845 |
| 52 | PRKCI | 1.01985562 |
| 53 | PRKAA2 | 1.00566905 |
| 54 | RIPK1 | 0.99086465 |
| 55 | PBK | 0.98881710 |
| 56 | MAP3K7 | 0.95013587 |
| 57 | STK24 | 0.94362451 |
| 58 | IRAK1 | 0.94284435 |
| 59 | LRRK2 | 0.93663522 |
| 60 | MATK | 0.93009702 |
| 61 | JAK2 | 0.90502750 |
| 62 | ADRBK1 | 0.89472463 |
| 63 | MAP3K11 | 0.84561352 |
| 64 | MAP3K10 | 0.84165809 |
| 65 | TRPM7 | 0.83888118 |
| 66 | CDK6 | 0.83351202 |
| 67 | TRIB3 | 0.81612830 |
| 68 | MUSK | 0.80217511 |
| 69 | PRKCE | 0.79990163 |
| 70 | STK10 | 0.79413191 |
| 71 | MAP2K1 | 0.79006928 |
| 72 | NLK | 0.77037557 |
| 73 | TGFBR1 | 0.74935064 |
| 74 | MAP3K1 | 0.74927791 |
| 75 | LATS2 | 0.73818236 |
| 76 | TRIM28 | 0.73277785 |
| 77 | TGFBR2 | 0.72768379 |
| 78 | MAPK4 | 0.69925505 |
| 79 | BCR | 0.68835224 |
| 80 | GSK3A | 0.67475247 |
| 81 | GRK6 | 0.67389586 |
| 82 | TBK1 | 0.67066585 |
| 83 | DAPK2 | 0.66231411 |
| 84 | PRKCZ | 0.65926271 |
| 85 | PTK2 | 0.65567295 |
| 86 | EPHA3 | 0.65121008 |
| 87 | CSNK1A1 | 0.64721390 |
| 88 | RPS6KB2 | 0.62617744 |
| 89 | PKN2 | 0.62155056 |
| 90 | EPHB1 | 0.58189493 |
| 91 | CDK3 | 0.57972274 |
| 92 | PRKACG | 0.57818415 |
| 93 | FGFR3 | 0.56239529 |
| 94 | JAK1 | 0.55857687 |
| 95 | MAP2K3 | 0.55620856 |
| 96 | STK3 | 0.55607325 |
| 97 | NUAK1 | 0.55569427 |
| 98 | CAMK2G | 0.53963658 |
| 99 | DYRK2 | 0.53411143 |
| 100 | CAMK2D | 0.53112133 |
| 101 | IKBKE | 0.51789302 |
| 102 | NME2 | 0.49305090 |
| 103 | IRAK3 | 0.48570607 |
| 104 | PTK2B | 0.48480048 |
| 105 | OXSR1 | 0.45880671 |
| 106 | CAMK2A | 0.43829631 |
| 107 | TIE1 | 0.43407599 |
| 108 | MYLK | 0.43340347 |
| 109 | TAOK1 | 0.41533140 |
| 110 | KDR | 0.40775792 |
| 111 | DYRK3 | 0.40492900 |
| 112 | PHKG2 | 0.40242692 |
| 113 | PHKG1 | 0.40242692 |
| 114 | PRKCQ | 0.40193228 |
| 115 | PDPK1 | 0.40127815 |
| 116 | PRKACA | 0.40022507 |
| 117 | MAP4K1 | 0.40016786 |
| 118 | MAPK12 | 0.39131807 |
| 119 | PINK1 | 0.38168607 |
| 120 | MAP3K12 | 0.37917660 |
| 121 | FLT3 | 0.37390771 |
| 122 | PRKCA | 0.37016570 |
| 123 | ERBB3 | 0.36668467 |
| 124 | MAP3K5 | 0.36105478 |
| 125 | MAP3K4 | 0.35871372 |
| 126 | HIPK2 | 0.35371046 |
| 127 | PRKAA1 | 0.34792513 |
| 128 | IGF1R | 0.34723887 |
| 129 | KIT | 0.33960206 |
| 130 | MAPK7 | 0.33701004 |
| 131 | PRKD1 | 0.32510293 |
| 132 | MAP3K6 | 0.31672272 |
| 133 | CSK | 0.30619268 |
| 134 | IKBKB | 0.30618284 |
| 135 | PRKCD | 0.29058806 |
| 136 | BLK | 0.28067871 |
| 137 | ABL1 | 0.27314049 |
| 138 | CHUK | 0.27024345 |
| 139 | GRK5 | 0.26202878 |
| 140 | PAK3 | 0.23895864 |
| 141 | ITK | 0.22527946 |
| 142 | BRSK2 | 0.22441495 |
| 143 | PDK2 | 0.21764995 |
| 144 | EPHA4 | 0.19327769 |
| 145 | MAPKAPK5 | 0.18665549 |
| 146 | AKT3 | 0.18662479 |
| 147 | PRKCG | 0.18605034 |
| 148 | SRC | 0.18366029 |
| 149 | MAPKAPK2 | 0.18350551 |
| 150 | MKNK2 | 0.17551227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.27101958 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33029844 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.24743943 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.02049978 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99588346 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.65858091 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52212139 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.50162826 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.49429483 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.46366600 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41227082 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.40923043 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.36427363 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.29855909 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28726381 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.18812086 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.16216174 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02724191 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.02007182 |
| 20 | Retinol metabolism_Homo sapiens_hsa00830 | 1.98195033 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89802898 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88470596 |
| 23 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.79680750 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77666683 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.75842011 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75507034 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.74596353 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71629583 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.67126244 |
| 30 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.64137280 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60439009 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.56468605 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.55795032 |
| 34 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.54257262 |
| 35 | Bile secretion_Homo sapiens_hsa04976 | 1.50385108 |
| 36 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.49050473 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48262801 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.47860807 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.46904581 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.41746930 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40358944 |
| 42 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.37801641 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36412779 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35127597 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.28705521 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27738643 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.26984831 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.25036805 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24298651 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.19708219 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19613921 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 1.16697293 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14752369 |
| 54 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.06456070 |
| 55 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.05498766 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01107006 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98121926 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95511273 |
| 59 | * Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95425790 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.94004420 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.93542980 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.92981106 |
| 63 | Allograft rejection_Homo sapiens_hsa05330 | 0.89053105 |
| 64 | * Glutathione metabolism_Homo sapiens_hsa00480 | 0.87730288 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.87622701 |
| 66 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85390790 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83720487 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.80382888 |
| 69 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79842191 |
| 70 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79568959 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78892578 |
| 72 | * Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.76249649 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.71786669 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.69964690 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67138127 |
| 76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65219910 |
| 77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63604251 |
| 78 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62553482 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59638516 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58124684 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.53274431 |
| 82 | Taste transduction_Homo sapiens_hsa04742 | 0.50867027 |
| 83 | Renin secretion_Homo sapiens_hsa04924 | 0.49201468 |
| 84 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.48971738 |
| 85 | Salivary secretion_Homo sapiens_hsa04970 | 0.46851773 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.46567651 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.44509767 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.42418852 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41752759 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.41603519 |
| 91 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38165326 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37226255 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.35902968 |
| 94 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33329619 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32668034 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32287973 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23313888 |
| 98 | Nicotine addiction_Homo sapiens_hsa05033 | 0.23185159 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.21728887 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21407190 |
| 101 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.18921788 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.16995207 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.16589141 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16350773 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.15396147 |
| 106 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15086749 |
| 107 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.14628713 |
| 108 | Olfactory transduction_Homo sapiens_hsa04740 | 0.13629401 |
| 109 | Protein export_Homo sapiens_hsa03060 | 0.13564916 |
| 110 | Cocaine addiction_Homo sapiens_hsa05030 | 0.13488354 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.13305678 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.09690044 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.08027468 |
| 114 | Prion diseases_Homo sapiens_hsa05020 | 0.07990969 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.07736439 |
| 116 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.07082067 |
| 117 | Ribosome_Homo sapiens_hsa03010 | 0.04404114 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.03534513 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.01081180 |
| 120 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.00891016 |
| 121 | Pertussis_Homo sapiens_hsa05133 | -0.2089999 |
| 122 | Basal cell carcinoma_Homo sapiens_hsa05217 | -0.2056668 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.1852670 |
| 124 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1670378 |
| 125 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1606901 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1455813 |
| 127 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1449548 |
| 128 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1090634 |
| 129 | Amoebiasis_Homo sapiens_hsa05146 | -0.0964174 |
| 130 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0716336 |
| 131 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0470741 |
| 132 | Bladder cancer_Homo sapiens_hsa05219 | -0.0422999 |
| 133 | Hepatitis C_Homo sapiens_hsa05160 | -0.0229260 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0169390 |

